Clinical Trials Browser

Unknown × Hematologic Neoplasms × Myeloid × Clear all

Multiple Chronic Conditions, Leukemia, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Hematologic Neoplasms

NCT05001386 2022-03-17

ESAAC

Phase NA Unknown

800 enrolled

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hypersensitivity, Lymphoproliferative Disorders, Multiple Myeloma, Myeloproliferative Disorders, Hematologic Neoplasms

NCT05175508 2022-01-03

Aza With or Without ATRA in Newly Diagnosed Unfit AML or Intermediate,High or Very High Risk MDS

Phase 2/3 Unknown

180 enrolled

MyeloidOther hematologic neoplasm

Frailty, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT03800095 2021-03-24

CALVI

Phase 3 Unknown

140 enrolled

LymphoidMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Lymphoma, Large B-Cell, Diffuse, Hematologic Neoplasms

NCT03091933 2017-12-06

GLIDE

Phase 1/2 Unknown

20 enrolled

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01217723 2010-10-08

Thymoglobulin in Unrelated Hematopoietic Progenitor Cell Transplantation

Phase 3 Unknown

198 enrolled

LymphoidMyeloidOther hematologic neoplasm

Lymphoma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Hematologic Neoplasms

Clinical Trials

Oral Adherence in Hematological Oncology Agents and Impact on Comorbid Therapy Adherence

ESAAC

Aza With or Without ATRA in Newly Diagnosed Unfit AML or Intermediate,High or Very High Risk MDS

CALVI

GLIDE

Thymoglobulin in Unrelated Hematopoietic Progenitor Cell Transplantation